EcoDrugPlus

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSOTSG00005025401
Gene Symbol: MMP14A
1 Cross references
192 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSOTSG00005013297
Gene Symbol: MMP14A
1 Cross references
192 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSOTSG00005039135
Gene Symbol: MMP14B
1 Cross references
190 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSOTSG00005007212
Gene Symbol: MMP14B
1 Cross references
190 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSOTSG00005034121
Gene Symbol: MMP2
1 Cross references
197 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSOTSG00005017318
Gene Symbol: MMP2
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSOTSG00005027625
Gene Symbol: MMP2
1 Cross references
197 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSOTSG00005004080
Gene Symbol: MMP9
1 Cross references
209 Possible Orthologues:

Matrix Metalloproteinase-9-Like

Ensembl ID : ENSOTSG00005007903
Gene Symbol: LOC112222403
3 Cross references
209 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSOTSG00005047135
Gene Symbol: MTOR
1 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSOTSG00005042924
Gene Symbol: MTOR
1 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSOTSG00005019283
Gene Symbol: MC1R
1 Cross references
154 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).